Climatotherapy At The Dead Sea For Atopic Dermatitis

NCT ID: NCT01307150

Last Updated: 2011-03-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-06-30

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the improvement in severity of Atopic Dermatitis and quality of life after 4 weeks of treatment in the Dead Sea.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

28 days treatment period, sun exposure and possibly Dead Sea baths after an exact given plan, discontinuation of all local Cortisone preparations, unlimited use of maintenance drags, doctor visit twice a week, continuous checks by the nurse.

Determination of the SCORAD index by the same doctor on arrival and departure. Before and after the treatment, the patient will answer written questionnaires regarding quality of life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atopic Dermatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Before and after treatment

SCORAD of each patient before and after treatment.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Minimum age of 18 years old

Exclusion Criteria

* Skin type - I
* Psoriasis patient in addition to Atopic Dermatitis
* Pregnancy
* Past malignancy
* Less then 2 weeks of treatment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hadassah Medical Organization

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Israel Ministry of Health

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arie Ingber, MD.

Role: STUDY_CHAIR

Hadassa Medical Organization IRB

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

DMZ Clinic

Jerusalem, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Arik Tzukert, DMD

Role: CONTACT

+972-(0)2-6776095

Hadas Lemberg, PhD

Role: CONTACT

+972-(0)2-6777572

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marco Harari, Dr.

Role: primary

+972-(0)8-6689200

References

Explore related publications, articles, or registry entries linked to this study.

Harari M, Shani J, Seidl V, Hristakieva E. Climatotherapy of atopic dermatitis at the Dead Sea: demographic evaluation and cost-effectiveness. Int J Dermatol. 2000 Jan;39(1):59-69. doi: 10.1046/j.1365-4362.2000.00840.x.

Reference Type RESULT
PMID: 10651969 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SK09409-HMO-CTIL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effects of Treatments on Atopic Dermatitis
NCT01631617 RECRUITING PHASE2
A Study for HSK44459 in Participants With Atopic Dermatitis
NCT06996912 ACTIVE_NOT_RECRUITING PHASE2